CLDN3 and 4 were also described as potent regulators of chemoresistance in ovarian and lung cancer, and targeting CLDN3 transcription with small molecules effectively suppressed cancer stemness and reversed their chemoresistance [26,32,33,34]. This evidence concerns the gene CLDN3 and lung carcinoma.